Bhupendar Tayal

Bhupendar Tayal practices at UAMS Medical Center in Little Rock, Arkansas, part of University of Arkansas for Medical Sciences.

Bhupendar Tayal's NPI, 1821668310, was assigned on June 28, 2021. Bhupendar Tayal holds Arkansas license E-18984.

Bhupendar Tayal's primary practice is UAMS Medical Center, at 4301 West Markham Street Mail Slot 612, Little Rock, AR 72205 in Pulaski County. The practice phone is (501) 686-5000.

Bhupendar Tayal's primary practice is UAMS Medical Center in Little Rock, Arkansas, part of University of Arkansas for Medical Sciences. Bhupendar Tayal is also affiliated with Baptist Health Medical Center-Little Rock. The medical group on file is UAMS - University of Arkansas for Medical Sciences. Dmand AI also links Bhupendar Tayal to 3 more hospitals, 2 medical groups and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Bhupendar Tayal practices, 6 sites in all. Vendor and product names are available with a free account.

Cardiovascular disease is Bhupendar Tayal's primary specialty in the NPI Registry, under taxonomy code 207RC0000X. Dmand AI has Bhupendar Tayal's licenses on file in 2 states: Arkansas and Texas.

CMS data shows 1,247 Medicare services from Bhupendar Tayal across 11 procedure codes in 2024, for 677 Medicare patients. Medicare paid $34,535 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 677 Medicare patients who saw Bhupendar Tayal in 2024. The largest group is 65 to 74, with 275 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 14% are also on Medicaid. Their average risk score is 2.15, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Bhupendar Tayal's median patient age at 68, with 55% women.

In 2024, Bhupendar Tayal wrote 620 Medicare Part D claims for 127 patients. 87% of them were for generic drugs. CMS names the drug for 560 of them, across 17 drugs with 11 or more claims each, at $63,305 in total drug cost. In 2023, CMS named 205 claims across 10 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 81 out of 100 for Bhupendar Tayal for performance year 2024, reported as part of a group. Bhupendar Tayal accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

CMS Open Payments shows 61 general payments to Bhupendar Tayal from 21 drug and device companies from 2022 to 2025. Food and beverage make up the largest share, 100% of the total. Pfizer Inc. paid the most, $169.